Garlic Intake And Biomarkers Of Cancer Risk
1 other identifier
interventional
18
1 country
1
Brief Summary
This study is being done to study the healthful benefits of eating garlic. Previous studies suggest that garlic may help prevent cancer. The investigators are recruiting healthy volunteers to participate in a study to determine the ways in which eating garlic may reduce cancer risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 8, 2011
CompletedFirst Posted
Study publicly available on registry
February 10, 2011
CompletedJune 2, 2017
February 1, 2011
1 month
February 8, 2011
June 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Garlic metabolites
Garlic metabolites will be measured in blood and urine.
Day 11 of each treatment period -- before and 3 hours after treatment
Markers of gene expression
Lymphocyte microarray analysis, lymphocyte DNA genotyping. Microarray results will be confirmed by RT-PCR.
Day 11 of each treatment period -- before and 3 hours after treatment
DNA damage
Comet assay, 8-oxo-dG, histone analysis
Day 11 of each treatment period -- before and 3 hours after treatment
Oxidative stress
Serum nitrate/nitrite, malondyaldehyde, glutathione, glutathione reductase, glutathione S-transferase, catalase, protein carbonyls, F2-isoprostanes.
Day 11 of each treatment period -- before and 3 hours after treatment
Biomarkers of inflammation
C-reactive protein (CRP), vascular endothelial growth factor, IL-1, IL-6, TNF-α.
Day 11 of each treatment period -- before and 3 hours after treatment
Study Arms (2)
Control
OTHER270 kcal White bread with 15 g margarine
Garlic Treatment
OTHER270 kcal white bread with 15 g margarine and 5 g crushed garlic
Interventions
Subjects will consume a garlic-free diet for 10 days. On day 11, subjects will consume 270 kcal white bread with 15 g margarine.
Subjects will consume a garlic-free diet for 10 days. On day 11, subjects will consume 270 kcal white bread with 15 g margarine and 5 g crushed garlic.
Eligibility Criteria
You may qualify if:
- Age 40-80 years
You may not qualify if:
- Younger than 40 years old or older than 80 years old
- Use of blood-thinning medications such as Coumadin (warfarin), Dicumarol (dicumarol), or Miradon (anisinidione)
- Presence of kidney disease, liver disease, gout, certain cancers, thyroid disease, gastrointestinal, other metabolic diseases or malabsorption syndromes.
- Have been pregnant during the previous 12 months, are currently pregnant or lactating, or plan to become pregnant during the study
- Follicle stimulating hormone levels above 35 mIU/mL serum
- Type 2 diabetes requiring the use of oral antidiabetic agents or insulin
- History of eating disorders or other dietary patterns which are not consistent with the dietary intervention (e.g., vegetarians, very low fat diets, high protein diets)
- Use of prescription or over-the-counter antiobesity medications or supplements (e.g., phenylpropanalamine, ephedrine, caffeine) during and for at least 6 months prior to the start of the study or a history of a surgical intervention for obesity
- Active cardiovascular disease (such as a heart attack or procedure within the past three months or participation in a cardiac rehabilitation program within the last three months, stroke, or history/treatment for transient ischemic attacks in the past three months, or documented history of pulmonary embolus in the past six months).
- Use of any tobacco products in past 6 months
- Use of oral or IV antibiotics during the month preceding the study or during the study
- Unwillingness to abstain from vitamin, mineral, and herbal supplements for two weeks prior to the study and during the study
- Known (self-reported) allergy or adverse reaction to garlic
- Inability to metabolize garlic
- Unable or unwilling to give informed consent or communicate with study staff
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USDA Beltsville Human Nutrition Research Center
Beltsville, Maryland, 20705, United States
Related Publications (1)
Charron CS, Dawson HD, Albaugh GP, Solverson PM, Vinyard BT, Solano-Aguilar GI, Molokin A, Novotny JA. A Single Meal Containing Raw, Crushed Garlic Influences Expression of Immunity- and Cancer-Related Genes in Whole Blood of Humans. J Nutr. 2015 Nov;145(11):2448-55. doi: 10.3945/jn.115.215392. Epub 2015 Sep 30.
PMID: 26423732DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Physiologist
Study Record Dates
First Submitted
February 8, 2011
First Posted
February 10, 2011
Study Start
July 1, 2010
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
June 2, 2017
Record last verified: 2011-02
Data Sharing
- IPD Sharing
- Will not share